Oncolix, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in Houston, Texas. The company focuses on the development of novel cancer therapeutics.
Subscribe to see Oncolix, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oncolix, Inc. is a company headquartered in Houston, United States. It has raised at least $6.9M across the 4 funding rounds on record. Its most recent funding round raised $250,000 in January 2017. Xcout tracks 1 named person at Oncolix, Inc., including John Doe (CEO).
As of 16 November 2026. Source: Xcout Intel.
At least $6.9M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $250,000 | — | |
| SEC Form D filing | $150,000 | — | |
| Seed | $2M | 3 named | |
| Series A | $4.5M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 8 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Oncolix, Inc.'s closest competitors — see the full list of competitors and alternatives →
DNAtrix Inc. is a biotechnology company headquartered in Houston, Texas, focused on the development of novel cancer therapies.
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company incorporated in Delaware and based in Houston, Texas, developing cancer therapies.
iOncologi, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of intractable solid tumors.
Aravive Biologics, Inc. is a clinical-stage biotechnology company based in Houston, Texas, focused on developing treatments for cancer and fibrotic diseases.
Ollin Biosciences is a clinical-stage biopharmaceutical holding company established in 2023 and headquartered in Austin, Texas, dedicated to developing therapeutics.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Oncolix, Inc.? Suggest a correction · Work at Oncolix, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.